Your fact-checks will appear here
American multinational pharmaceutical and biotechnology corporation
Michael Yeadon is a former Pfizer vice‑president and chief scientist for a respiratory/allergy research unit who has repeatedly made public statements opposing COVID‑19 restrictions and questioning va...
President Trump publicly claimed extraordinarily large drug-price reductions — citing figures like “500%, 600%, 1,000%, 1,500%” — during July and August 2025 remarks and in subsequent events; fact‑che...
Reported tallies of "deaths from COVID vaccine" vary widely because they mix raw, unverified reports with adjudicated findings; passive surveillance systems like VAERS show tens of thousands of report...
Available regulatory and manufacturer materials describe Prevnar 20 (PCV20) as a single-dose adult vaccine that provides "lasting protection" against 20 pneumococcal serotypes and is recommended by AC...
Public, consumer-facing lot‑number lookup tools exist for some COVID‑19 vaccines (for example Moderna’s Vial Lookup and manufacturer/Janssen checkers), but Pfizer (Comirnaty/BNT162b2) does not maintai...
Large surveillance studies and safety summaries show different rare long‑term risks for the Janssen (J&J) adenovirus vaccine versus mRNA vaccines: J&J has been associated with rare thrombosis with thr...
Pfizer and Moderna mRNA vaccines produce (injection-site pain, fatigue, headache, fever) that are generally mild and resolve in days, with likely due to a higher mRNA dose . Rare serious events differ...
Clinical-trial and public-health reporting consistently list local pain at the injection site, fatigue, headache, muscle aches and chills as the most commonly reported side effects after Pfizer’s COVI...
Vaccine manufacturers do make from vaccines, but the scale and context vary by company, product, and time period; COVID‑19 vaccines produced especially large revenues and profits for major firms durin...
Clinical surveillance through 2022–2025 finds , with Janssen linked more to thrombosis with thrombocytopenia syndrome (TTS) and Guillain-Barré syndrome (GBS), and mRNA vaccines showing higher signals ...
Michael (Mike) Yeadon, a former Pfizer allergy and respiratory research vice president who left the company in 2011, has made repeated claims about Pfizer, COVID-19 vaccines, fertility, children’s saf...
The assembled evidence identifies as the most consistently observed rare long-term adverse events associated with the Pfizer-BioNTech BNT162b2 vaccine, particularly after mRNA dosing in younger age gr...
Clinical-trial and post‑authorization reports for the 2024–2025 updated COVID vaccines show predictable, mostly short‑lived reactions — injection‑site pain/tenderness, fatigue, muscle aches, fever, he...
Available reporting shows no record of Pfizer issuing a public rebuttal to Michael Yeadon’s high‑profile claims; when asked about Yeadon’s assertions, a Pfizer spokesman declined to comment, and news ...
The most common COVID‑19 vaccine reactions are short‑lived local and systemic symptoms: injection‑site pain, redness and swelling, plus fatigue, headache, muscle aches and low‑grade fever; these typic...
OpenSecrets and related reporting show that pharmaceutical/health‑product PACs spent about $16.05 million on federal candidates in the 2024 cycle . Multiple outlets compiling OpenSecrets data list top...
Available reporting shows large pharmaceutical companies and the industry trade group PhRMA gave sizable donations to Donald Trump’s 2025 inauguration committee — filings and press reports cite indivi...
Available reporting links Johnson & Johnson’s (J&J/Janssen) adenovirus‑vector COVID‑19 vaccine to a rare syndrome—thrombosis with thrombocytopenia syndrome (TTS)—with roughly 57–60 reported U.S. cases...
Dr. David E. Martin is presented in the provided materials as a researcher who links historical coronavirus cultivation, patents, and pandemic-era policy decisions to suspicions about COVID-19 origins...
mRNA COVID-19 vaccines can trigger short-lived changes in immune markers and—in rare cases—cause inflammatory conditions such as myocarditis; major public-health reviews and cohort studies find no sus...